| High level expression of the HMGI (Y) gene during embryonic development. G Chiappetta, V Avantaggiato, R Visconti, M Fedele, S Battista, ... Oncogene 13 (11), 2439-2446, 1996 | 386 | 1996 |
| New insights on oxidative stress in cancer R Visconti, D Grieco Current Opinion in Drug Discovery and Development 12 (2), 240-245, 2009 | 370 | 2009 |
| RET/PTC oncogene activation is an early event in thyroid carcinogenesis. G Viglietto, G Chiappetta, FJ Martinez-Tello, FH Fukunaga, G Tallini, ... Oncogene 11 (6), 1207-1210, 1995 | 350 | 1995 |
| Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword R Visconti, R Della Monica, D Grieco Journal of Experimental & Clinical Cancer Research 35, 1-8, 2016 | 346 | 2016 |
| Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes D Franchimont, J Galon, M Gadina, R Visconti, YJ Zhou, M Aringer, ... The Journal of Immunology 164 (4), 1768-1774, 2000 | 311 | 2000 |
| Signaling by type I and II cytokine receptors: ten years after M Gadina, D Hilton, JA Johnston, A Morinobu, A Lighvani, YJ Zhou, ... Current opinion in immunology 13 (3), 363-373, 2001 | 296 | 2001 |
| STAT4 serine phosphorylation is critical for IL-12-induced IFN-γ production but not for cell proliferation A Morinobu, M Gadina, W Strober, R Visconti, A Fornace, C Montagna, ... Proceedings of the National Academy of Sciences 99 (19), 12281-12286, 2002 | 260 | 2002 |
| Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells MT Berlingieri, G Manfioletti, M Santoro, A Bandiera, R Visconti, ... Molecular and Cellular Biology 15 (3), 1545-1553, 1995 | 243 | 1995 |
| The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. G Chiappetta, A Bandiera, MT Berlingieri, R Visconti, G Manfioletti, ... Oncogene 10 (7), 1307-1314, 1995 | 226 | 1995 |
| Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression R Visconti, J Cerutti, S Battista, M Fedele, F Trapasso, K Zeki, MP Miano, ... Oncogene 15 (16), 1987-1994, 1997 | 225 | 1997 |
| Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor α D Franchimont, J Galon, MS Vacchio, S Fan, R Visconti, DM Frucht, ... The Journal of immunology 168 (5), 2212-2218, 2002 | 213 | 2002 |
| Importance of the MKK6/p38 pathway for interleukin-12–induced STAT4 serine phosphorylation and transcriptional activity R Visconti, M Gadina, M Chiariello, EH Chen, LF Stancato, JS Gutkind, ... Blood, The Journal of the American Society of Hematology 96 (5), 1844-1852, 2000 | 186 | 2000 |
| Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret M Chiariello, R Visconti, F Carlomagno, RM Melillo, C Bucci, ... Oncogene 16 (19), 2435-2445, 1998 | 159 | 1998 |
| Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation RA Ortmann, T Cheng, R Visconti, DM Frucht, JJ O'Shea Arthritis Research & Therapy 2, 1-17, 1999 | 151 | 1999 |
| Rat protein tyrosine phosphatase η suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27Kip1 F Trapasso, R Iuliano, A Boccia, A Stella, R Visconti, P Bruni, ... Molecular and cellular biology, 2000 | 131 | 2000 |
| The docking molecule gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common γ chain-using cytokines M Gadina, C Sudarshan, R Visconti, YJ Zhou, H Gu, BG Neel, JJ O'Shea Journal of Biological Chemistry 275 (35), 26959-26966, 2000 | 121 | 2000 |
| Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival G De Vita, RM Melillo, F Carlomagno, R Visconti, MD Castellone, ... Cancer research 60 (14), 3727-3731, 2000 | 115 | 2000 |
| Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B D Salvatore, RM Melillo, C Monaco, R Visconti, G Fenzi, G Vecchio, ... Cancer research 61 (4), 1426-1431, 2001 | 98 | 2001 |
| Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways F Candotti, L Notarangelo, R Visconti, J O’Shea The Journal of clinical investigation 109 (10), 1261-1269, 2002 | 84 | 2002 |
| Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines. J Cerutti, F Trapasso, C Battaglia, L Zhang, ML Martelli, R Visconti, ... Clinical cancer research: an official journal of the American Association …, 1996 | 80 | 1996 |
